AAAAAA

   
Results: 1-19 |
Results: 19
New PCR-based method for the Sp1 site polymorphism in the COL1A1 gene
Authors: Vinkanharju, A Melkko, T Risteli, J Risteli, L
Citation: A. Vinkanharju et al., New PCR-based method for the Sp1 site polymorphism in the COL1A1 gene, CLIN CH L M, 39(7), 2001, pp. 624-626
Aminoterminal propeptide of the alpha 1-homotrimer variant of human type Iprocollagen (hotPINP) in malignant pleural effusion
Authors: Kauppila, S Jukkola, A Melkko, J Risteli, L Turpeeniemi-Hujanen, T Vuorinen, K Risteli, J
Citation: S. Kauppila et al., Aminoterminal propeptide of the alpha 1-homotrimer variant of human type Iprocollagen (hotPINP) in malignant pleural effusion, ANTICANC R, 21(4A), 2001, pp. 2293-2296
Type I collagen turnover and cross-linking are increased in irradiated skin of breast cancer patients
Authors: Sassi, ML Jukkola, A Riekki, R Hoyhtya, M Risteli, L Oikarinen, A Risteli, J
Citation: Ml. Sassi et al., Type I collagen turnover and cross-linking are increased in irradiated skin of breast cancer patients, RADIOTH ONC, 58(3), 2001, pp. 317-323
Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: Loss of antigenicity by treatment with cathepsin K
Authors: Sassi, ML Eriksen, H Risteli, L Niemi, S Mansell, J Gowen, M Risteli, J
Citation: Ml. Sassi et al., Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: Loss of antigenicity by treatment with cathepsin K, BONE, 26(4), 2000, pp. 367-373
Decreased protein C activation is associated with abnormal collagen turnover in the intraalveolar space of patients with interstitial lung disease
Authors: Yasui, H Gabazza, EC Taguchi, O Risteli, J Risteli, L Wada, H Yuda, H Kobayashi, T Kobayashi, H Suzuki, K Adachi, Y
Citation: H. Yasui et al., Decreased protein C activation is associated with abnormal collagen turnover in the intraalveolar space of patients with interstitial lung disease, CL APPL T-H, 6(4), 2000, pp. 202-205
Increased amount of type III pN-collagen in human abdominal aortic aneurysms: Evidence for impaired type III collagen fibrillogenesis
Authors: Bode, MK Soini, Y Melkko, J Satta, J Risteli, L Risteli, J
Citation: Mk. Bode et al., Increased amount of type III pN-collagen in human abdominal aortic aneurysms: Evidence for impaired type III collagen fibrillogenesis, J VASC SURG, 32(6), 2000, pp. 1201-1207
Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125
Authors: Simojoki, M Santala, M Risteli, J Risteli, L Kauppila, A
Citation: M. Simojoki et al., Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125, ANTICANC R, 20(6C), 2000, pp. 4655-4660
Type I and III collagens in human colon cancer and diverticulosis
Authors: Bode, MK Karttunen, TJ Makela, J Risteli, L Risteli, J
Citation: Mk. Bode et al., Type I and III collagens in human colon cancer and diverticulosis, SC J GASTR, 35(7), 2000, pp. 747-752
Complete processing of type III collagen in atherosclerotic plaques
Authors: Bode, MK Mosorin, M Satta, J Risteli, L Juvonen, T Risteli, J
Citation: Mk. Bode et al., Complete processing of type III collagen in atherosclerotic plaques, ART THROM V, 19(6), 1999, pp. 1506-1511
Type I and type III collagen metabolites as predictors of clinical outcomein epithelial ovarian cancer
Authors: Santala, M Simojoki, M Risteli, J Risteli, L Kauppila, A
Citation: M. Santala et al., Type I and type III collagen metabolites as predictors of clinical outcomein epithelial ovarian cancer, CLIN CANC R, 5(12), 1999, pp. 4091-4096
The extracellular matrix in skin tumor development - a morphological study
Authors: Stenback, F Makinen, MJ Jussila, T Kauppila, S Risteli, J Talve, L Risteli, L
Citation: F. Stenback et al., The extracellular matrix in skin tumor development - a morphological study, J CUT PATH, 26(7), 1999, pp. 327-338
Preoperative high type I collagen degradation marker ICTP reflects advanced breast cancer
Authors: Keskikuru, R Kataja, V Kosma, VM Eskelinen, M Uusitupa, M Johansson, R Risteli, L Risteli, J Jukkola, A
Citation: R. Keskikuru et al., Preoperative high type I collagen degradation marker ICTP reflects advanced breast cancer, ANTICANC R, 19(5C), 1999, pp. 4481-4484
Characterization of type I collagen synthesis and maturation in uterine carcinosarcomas
Authors: Kauppila, S Stenback, F Kacinski, BM Carcangiu, MWL Risteli, J Risteli, L
Citation: S. Kauppila et al., Characterization of type I collagen synthesis and maturation in uterine carcinosarcomas, CANCER, 86(7), 1999, pp. 1299-1306
Type I collagen metabolites as tumor markers in patients with lung carcinoma
Authors: Kobayashi, T Gabazza, EC Taguchi, O Risteli, J Risteli, L Kobayashi, H Yasui, H Yuda, H Sakai, T Kaneda, M Adachi, Y
Citation: T. Kobayashi et al., Type I collagen metabolites as tumor markers in patients with lung carcinoma, CANCER, 85(9), 1999, pp. 1951-1957
Cross linked telopeptides of type I and III collagens in malignant ovariantumours in vivo
Authors: Kauppila, S Bode, MK Stenback, F Risteli, L Risteli, J
Citation: S. Kauppila et al., Cross linked telopeptides of type I and III collagens in malignant ovariantumours in vivo, BR J CANC, 81(4), 1999, pp. 654-661
The value of synovial fluid analysis in the assessment of knee joint destruct-ion in arthritis in a three year follow up study
Authors: Aman, S Risteli, J Luukkainen, R Risteli, L Kauppi, M Nieminen, P Hakala, M
Citation: S. Aman et al., The value of synovial fluid analysis in the assessment of knee joint destruct-ion in arthritis in a three year follow up study, ANN RHEUM D, 58(9), 1999, pp. 559-562
Immunohistochemical study of type I collagen turn-over and of matrix metalloproteinases in chromoblastomycosis before and after treatment by terbinafine
Authors: Esterre, P Risteli, L Ricard-Blum, S
Citation: P. Esterre et al., Immunohistochemical study of type I collagen turn-over and of matrix metalloproteinases in chromoblastomycosis before and after treatment by terbinafine, PATH RES PR, 194(12), 1998, pp. 847-853
Circulating type I collagen degradation products: a new serum marker for clinical severity in patients with scleroderma?
Authors: Hunzelmann, N Risteli, J Risteli, L Sacher, C Vancheeswaran, R Black, C Krieg, T
Citation: N. Hunzelmann et al., Circulating type I collagen degradation products: a new serum marker for clinical severity in patients with scleroderma?, BR J DERM, 139(6), 1998, pp. 1020-1025
Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancer
Authors: Santala, M Risteli, J Risteli, L Puistola, U Kacinski, BM Stanley, ER Kauppila, A
Citation: M. Santala et al., Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancer, BR J CANC, 77(11), 1998, pp. 1825-1831
Risultati: 1-19 |